Brief: ProQR Therapeutics Q3 EPS EUR -0.1
06/11/2025 12:00
Nov 06 (Reuters) - ProQR Therapeutics Q3 revenue EUR 2.882 million vs. IBES estimate EUR 4.37 million. Q3 operating income EUR -11.284 million Q3 net income EUR -11.006 million Q3 basic EPS EUR -0.1
Recent news on ProQR Therapeutics NV
See all newsProQR Therapeutics NV reports results for the quarter ended June 30 - Earnings Summary
ProQR Q2 revenue more than doubles
Brief: ProQR Therapeutics Q2 EPS EUR -0.08
ProQR Therapeutics NV expected to post a loss of 11 cents a share - Earnings Preview
ProQR Therapeutics NV expected to post a loss of 11 cents a share - Earnings Preview